Skin lightening treatment is designed to decrease excessive melanin in the skin
Preclinical research highlights pathways tied to angiogenesis and collagen organization, which helps explain why lifters use it when joints, tendons, or soft tissue feel overworked
Serious adverse events were reported in 4% of subjects treated with TALTZ (0.05 per subject-year of follow-up) and none in the subjects treated with placebo
Normal healing response, not specific to tirzepatide
With consistent daily use, many users begin to notice visible changeslike reduced shedding, improved scalp condition, and signs of regrowtharound the 120 to 150 day mark
Fig S3A, B), and this localization pattern was not affected by ML162 (Fig